TY - JOUR
T1 - Contrast enhancement of iohexol-cisplatin-gelatin complex under computed tomography imaging
AU - Liu, Wei Hung
AU - Wang, Yang Kao
AU - Wu, Chi Chang
AU - Deng, Win Pin
AU - Lin, Kuang Hsun
AU - Lo, Wen Cheng
AU - Tseng, Ching Li
PY - 2014/5/1
Y1 - 2014/5/1
N2 - X-ray computed tomography (CT) is one of the most powerful non-invasive diagnostic techniques nowadays. The iodinated molecules used as CT contrast agents in the clinic have short circulation times in the body, which significantly restrict its applications. Furthermore, some patients are hypersensitive to iodine. So, researchers have made tremendous efforts to improve the property of iodine. Besides, cis-diammineplatinum (II) dichloride (cisplatin), a major chemo agent for cancer treatment, possess higher X-ray attenuation coefficient being a CT contrast agent. The incorporation of cisplatin with an iodinated agent could facilitate the quality of CT images and damage cancer cells simultaneously. To reduce toxicity of a contrast agent, polymer matrix, gelatin, was incorporated for avoiding contact with nontarget cells. In this study, we combined the iodine contrast agent, 1,3-N-bis (2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4, 6-triiodobenzene-1,3-dicarboxamide (iohexol), with cisplatin, and then examined them in a micro CT with different X-ray tube voltages (50 kV, 80 kV, 100 kV) to find optimal scanning conditions for imaging. As expected, iohexol combined with cisplatin enhanced X-ray attenuation and image contrast. The optimal CT image could be acquired at iohexol and cisplatin concentrations of 50 mg/ml and 3 mg/ml, respectively, under 80 kV irradiation. Finally, the iohexol-cisplatin- gelatin solution was then fabricated into nanoparticles of sizes about 240 nm, which may suitable for in vivo delivery.
AB - X-ray computed tomography (CT) is one of the most powerful non-invasive diagnostic techniques nowadays. The iodinated molecules used as CT contrast agents in the clinic have short circulation times in the body, which significantly restrict its applications. Furthermore, some patients are hypersensitive to iodine. So, researchers have made tremendous efforts to improve the property of iodine. Besides, cis-diammineplatinum (II) dichloride (cisplatin), a major chemo agent for cancer treatment, possess higher X-ray attenuation coefficient being a CT contrast agent. The incorporation of cisplatin with an iodinated agent could facilitate the quality of CT images and damage cancer cells simultaneously. To reduce toxicity of a contrast agent, polymer matrix, gelatin, was incorporated for avoiding contact with nontarget cells. In this study, we combined the iodine contrast agent, 1,3-N-bis (2,3-dihydroxypropyl)-5-[N-(2,3-dihydroxypropyl)acetamido]-2,4, 6-triiodobenzene-1,3-dicarboxamide (iohexol), with cisplatin, and then examined them in a micro CT with different X-ray tube voltages (50 kV, 80 kV, 100 kV) to find optimal scanning conditions for imaging. As expected, iohexol combined with cisplatin enhanced X-ray attenuation and image contrast. The optimal CT image could be acquired at iohexol and cisplatin concentrations of 50 mg/ml and 3 mg/ml, respectively, under 80 kV irradiation. Finally, the iohexol-cisplatin- gelatin solution was then fabricated into nanoparticles of sizes about 240 nm, which may suitable for in vivo delivery.
UR - http://www.scopus.com/inward/record.url?scp=84899853987&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899853987&partnerID=8YFLogxK
U2 - 10.1515/polyeng-2013-0223
DO - 10.1515/polyeng-2013-0223
M3 - Article
AN - SCOPUS:84899853987
SN - 0334-6447
VL - 34
SP - 267
EP - 271
JO - Journal of Polymer Engineering
JF - Journal of Polymer Engineering
IS - 3
ER -